Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13446-13455

  Saghafian Hedengren, Shanie ^a,c   Sohlberg, Ebba ^a   Theorell, Jakob ^b   Carvalho Queiroz, Claudia ^a   Nagy, Noémi ^c   Persson, Jan Olov ^d   Nilsson, Caroline ^e   Bryceson, Yenan T ^b   Sverremark Ekström, Eva ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e SACHS CHILDREN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA E ANTIGEN; INTERLEUKIN 12P70; INTERLEUKIN 15; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL MATURATION; CHILD; COCULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; EPSTEIN BARR VIRUS INFECTION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MIXED INFECTION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS LATENCY;

CELL DIFFERENTIATION; CHILD, PRESCHOOL; COHORT STUDIES; COINFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-12; INTERLEUKIN-15; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84888020316     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02382-13     Document Type: Article

References (50)

1. Hislop AD, Taylor GS, Sauce D, Rickinson AB. 2007. Cellular responses to viral infection in humans:lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617.
2. Loewendorf A, Benedict CA. 2010. Modulation of host innate and adaptive immune defenses by cytomegalovirus:timing is everything. J. Intern. Med. 267:483-501.
3. + T cells and their role in health and disease. Immunology 134:17-32.
4. Chattopadhyay PK, Betts MR, Price DA, Gostick E, Horton H, Roederer M, De Rosa SC. 2009. The cytolytic enzymes granyzme A, granzyme B, and perforin:expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85:88-97.
5. Chiang SC, Theorell J, Entesarian M, Meeths M, Mastafa M, Al-Herz W, Frisk P, Gilmour KC, Ifversen M, Langenskiold C, Machaczka M, Naqvi A, Payne J, Perez-Martinez A, Sabel M, Unal E, Unal S, Winiarski J, Nordenskjold M, Ljunggren HG, Henter JI, Bryceson YT. 2013. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood 121:1345-1356.
6. + T cells. Nat. Rev. Immunol. 11:645-657.
7. Chichocki F, Miller JS, Anderson SK, Bryceson YT. 2013. Epigenetic regulation of NK cell differentiation and effector functions. Front. Immunol. 4:55.
8. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25:331-342.
9. dim NK-cell differentiation uncoupled from NK-cell education. Blood 116:3853-3864.
10. Beziat V, Descours B, Parizot C, Debre P, Vieillard V. 2010. NK cell terminal differentiation:correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One 5:e11966. doi:10.1371/journal.pone.0011966.
11. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104:3664-3671.
12. Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, Roosnek E. 2008. Human NK cells can control CMV infection in the absence of T cells. Blood 112:914-915.
13. Monsivais-Urenda A, Noyola-Cherpitel D, Hernandez-Salinas A, Garcia-Sepulveda C, Romo N, Baranda L, Lopez-Botet M, Gonzalez-Amaro R. 2010. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 40:1418-1427.
14. + NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 108:14725-14732.
15. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107:3624-3631.
16. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/ NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187:813-818.
17. + NK-cell subset. Blood 116:3865-3874.
18. Sun JC, Lopez-Verges S, Kim CC, DeRisi JL, Lanier LL. 2011. NK cells and immune "memory." J. Immunol. 186:1891-1897.
19. Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, Lopez-Botet M. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194:38-41.
20. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, Michaelsson J, Malmberg KJ, Klingstrom J, Ahlm C, Ljunggren HG. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208:13-21.
21. + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42:447-457.
22. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-385.
23. + T cells. Exp. Gerontol. 39:1233-1243.
24. Nilsson C, Linde A, Montgomery SM, Gustafsson L, Nasman P, Blomberg MT, Lilja G. 2005. Does early EBV infection protect against IgE sensitization? J. Allergy Clin. Immunol. 116:438-444.
25. Saghafian-Hedengren S, Sundstrom Y, Sohlberg E, Nilsson C, Linde A, Troye-Blomberg M, Berg L, Sverremark-Ekstrom E. 2009. Herpesvirus seropositivity in childhood associates with decreased monocyte-induced NK cell IFN-γ production. J. Immunol. 182:2511-2517.
26. Saghafian-Hedengren S, Sverremark-Ekstrom E, Linde A, Lilja G, Nilsson C. 2010. Early-life EBV infection protects against persistent IgE sensitization. J. Allergy Clin. Immunol. 125:433-438.
27. Sohlberg E, Saghafian-Hedengren S, Rasul E, Marchini G, Nilsson C, Klein E, Nagy N, Sverremark-Ekstrom E. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-gamma. J. Immunol., in press. doi:10.4049/jimmunol.1301343.
28. White DW, Keppel CR, Schneider SE, Reese TA, Coder J, Payton JE, Ley TJ, Virgin HW, Fehniger TA. 2010. Latent herpesvirus infection arms NK cells. Blood 115:4377-4383.
29. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW, 4th. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447:326-329.
30. Wills-Karp M, Santeliz J, Karp CL. 2001. The germless theory of allergic disease:revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1:69-75.
31. Prendergast AJ, Klenerman P, Goulder PJ. 2012. The impact of differential antiviral immunity in children and adults. Nat. Rev. Immunol. 12:636-648.
32. Vercelli D. 2006. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr. Opin. Immunol. 18:733-737.
33. Garn H, Renz H. 2007. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology. 212:441-452.
34. Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K. 1998. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J. Med. Virol. 56:186-191.
35. Arcenas R, Widen RH. 2002. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol. 2:20.
36. Pass RF, Stagno S, Britt WJ, Alford CA. 1983. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J. Infect. Dis. 148:953-961.
37. Malmberg KJ, Beziat V, Ljunggren HG. 2012. Spotlight on NKG2C and the human NK-cell response to CMV infection. Eur. J. Immunol. 42:3141-3145.
38. Pappworth IY, Wang EC, Rowe M. 2007. The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing. J. Virol. 81:474-482.
39. Pak-Wittel MA, Yang L, Sojka DK, Rivenbark JG, Yokoyama WM. 2013. Interferon-gamma mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc. Natl. Acad. Sci. U.S.A. 110:E50-E59.
40. Strowig T, Brilot F, Arrey F, Bougras G, Thomas D, Muller WA, Munz C. 2008. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ. PLoS Pathog. 4:e27. doi:10.1371/journal.ppat.0040027.
41. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.
42. Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R. 2012. The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog. 8:e1002704. doi:10.1371/journal.ppat.1002704.
43. Hurley CK, Johnson AH. 2001. HLA type of EBV-transformed human B cell lines. Curr. Protoc. Immunol.Appendix 1G doi:10.1002/0471142735.ima01gs30.
44. Sun JC, Madera S, Bezman NA, Beilke JN, Kaplan MH, Lanier LL. 2012. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209:947-954.
45. Sharif-Askari E, Fawaz LM, Tran P, Ahmad A, Menezes J. 2001. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. J. Natl. Cancer Inst. 93:1724-1732.
46. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, Charrier S, Ryffel B, Cambi A, Figdor C, Vainchenker W, Galy A, Caignard A, Zitvogel L. 2004. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104:3267-3275.
47. Castillo EF, Schluns KS. 2012. Regulating the immune system via IL-15 transpresentation. Cytokine 59:479-490.
48. + T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198:1583-1593.
49. Sandalova E, Laccabue D, Boni C, Tan AT, Fink K, Ooi EE, Chua R, Shafaeddin-Schreve B, Ferrari C, Bertoletti A. 2010. Contribution of herpesvirus specific CD8 T cells to antiviral T cell response in humans. PLoS Pathog. 6:e1001051. doi:10.1371/journal.ppat.1001051.
50. + NK cells as rapid producers of abundant IFN-γ on activation. Proc. Natl. Acad. Sci. U.S.A. 108:728-732.